0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover348.39%IV-131.37%PremiumAug 16, 2024Expiry Date2.84Intrinsic Value100Multiplier18DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7495Delta0.1890Gamma0.73Leverage Ratio-0.0141Theta-0.0018Rho-0.54Eff Leverage0.0016Vega
Fortress Biotech Stock Discussion
- SEC Filing
Fortress Biotech Inc: FDA Accepted Nda Filing for Dfd-29 to Treat Inflammatory Lesions & Erythema of Rosacea in Adults; Pdufa Goal Date of Nov 4, 2024
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
$OptiNose(OPTN.US)$
when are the next date for $Checkpoint Therapeutics(CKPT.US)$ , $Fortress Biotech(FBIO.US)$ , and $Brainstorm Cell Therapeutics(BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
No comment yet